[ad_1]
SINGAPORE, July 22, 2024 /PRNewswire/ — QDX, a computational drug discovery corporate, nowadays introduced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology corporate, concentrated on undercover, in the past undrugged oncology goals.
QDX integrates its world-leading quantum mechanical simulation generation, supercomputing, synthetic knowledge, and deep drug discovery experience to move computational chemistry and drug discovery.
Peggy Scherle, PhD, CSO of Prelude, commented: “Computational approaches to drug discovery are showing increasing promise. We are pleased to work with the talented team at QDX to leverage their blend of high-performance computing, quantum simulations, and AI on these historically challenging targets.”
Loong Wang, Co-Founder and CEO of QDX, mentioned: “We are thrilled to be working with the team at Prelude to help break new ground on these programs. This collaboration with Prelude exemplifies the kind of bespoke partnerships that QDX engages in across academia and industry, deploying our best-in-class quantum technology, our massively parallel supercomputing, and AI systems.”
Kelvin Neu, MD, Co-Founder and Chair of QDX, added: “The accomplished biology and chemistry teams at Prelude have been very productive, generating a pipeline of small molecules against important and often challenging oncology targets. QDX has built a powerful platform by thoughtfully integrating complementary disciplines, guided by the practical needs and challenges of novel drug discovery, with a particular focus on select traditionally difficult-to-crack areas. We are honored that Prelude has chosen QDX to support them on these challenging targets and look forward to a productive collaboration.”
About QDX
QDX is a computational drug discovery corporate integrating quantum mechanical simulations, supercomputing, and synthetic knowledge. By means of growing untouched methods and algorithms from field up and optimizing current tool for contemporary {hardware}, QDX achieves large-scale molecular dynamics and quantum simulations with unrivaled pace and scale. From mini molecules to complete protein complexes, QDX makes quantum simulations pragmatic and related in programs reminiscent of drug discovery and fabrics science.
QDX’s cross-disciplinary staff makes a speciality of industrializing, specializing, and turning in at the contract of classical and quantum computational chemistry for a dimension of programs and industries. To start with specializing in drug discovery, QDX collaborates with researchers and corporations on complicated initiatives, offering distinctive insights and features via large-scale computations, quantum simulations, proprietary top quality quantum coaching knowledge, AI, and customized tool. QDX is a globally-minded corporate based totally in Singapore and Australia. For more info please seek advice from www.qdx.co.
SOURCE QDX
[ad_2]
Source link
